Iowanews Headlines

Press Release

Acute Myeloid Leukemia Pipeline Report | GlycoMimetics, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Takeda Oncology, Orca Bio, Gilead Sciences, and others.

DelveInsight’s, “Acute Myeloid Leukemia Pipeline Insight 2023” report provides comprehensive insights about 260+ companies and 260+ pipeline drugs in the Acute Myeloid Leukemia pipeline landscape. It covers the Acute Myeloid

Read Full Article

CAR-T Cell Therapy Competitive Landscape (Updated) | CASI Pharmaceuticals, Juventas Cell Therapy, Novartis, Poseida Therapeutics, Shanghai Unicar-Therapy Bio-medicine Technology, and others.

DelveInsight’s, “CAR T Cell Therapy Competitive Landscape 2023” report provides comprehensive insights about 250+ CAR-T Cell Therapy companies and 500+ drugs in CAR T – Cell Therapy Competitive landscape. It

Read Full Article

Gene therapy Competitive Landscape Report (Updated) | Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech, Replimune, and others.

DelveInsight’s, “Gene Therapy Competitive Landscape 2023” report provides comprehensive insights about 250+ Gene Therapy companies and 300+ Gene Therapy drugs in the Gene therapy Competitive landscape. It covers the Gene

Read Full Article

Bispecific Antibody Competitive Landscape Report (Updated) | Janssen, Amgen, Akeso, Zymeworks, Roche, IGM Biosciences, MacroGenics, Provention Bio, and others.

DelveInsight’s, “Bispecific antibody Competitive landscape, 2023,” report provides comprehensive insights about 250+ Bispecific Antibody companies and 300+ Bispecific Antibody drugs in Bispecific antibody Competitive landscape. It covers the Bispecific Antibody

Read Full Article

Antibody Drug Conjugate Competitie Landscape Report (Updated) | ImmunoGen, Inc., Seagen Inc, ADC Therapeutics, Mythic Therapeutics, Sutro Biopharma, Merck KGaA, and others.

DelveInsight’s, “Antibody Drug Conjugate Competitive Landscape, 2023,” report provides comprehensive insights about 180+ Antibody Drug Conjugate companies and 290+ Antibody

Read Full Article

Hodgkin’s Lymphoma Market Expected to Grow Steadily According to DelveInsight Analysis | ACD Therapeutics, Cstone Pharmaceuticals, 4SC, TG Therapeutics, Actiza Pharmaceutical Private Limited, Alkem

Hodgkin’s Lymphoma Market (Albany, USA) DelveInsight’s “Hodgkins Lymphoma Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of

Read Full Article

Sickle Cell Disease Pipeline Report: FDA, EMA, and PMDA Approvals, Treatments, Clinical Trials, and Companies by DelveInsight | Bellicum Pharmaceuticals, Novartis, Novo Nordisk, Vertex Pharmaceuticals

Sickle Cell Disease Pipeline (Albany, USA) DelveInsight’s ‘Sickle Cell Disease Pipeline Insight 2023‘ report provides comprehensive global coverage of available,

Read Full Article

Beta Thalassemia Market to witness growth by 2032, estimates DelveInsight | Novartis, Merck, Bristol Myers Squibb, Celgene, Chiesi Farmaceutici S.p.A, Bluebird Bio, Agios Pharmaceuticals, Imara Inc.

Beta Thalassemia Market (Albany, USA) DelveInsight’s “Beta Thalassemia Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of

Read Full Article

Alzheimer’s Disease Market Forecast 2032: Therapies, FDA Approvals, Companies and Patient based Forecast by DelveInsight | Eisai, Biogen, Changchun Huayang High-tech Co., Roche, vTv Therapeutics

Alzheimer’s Disease Market (Albany, USA) DelveInsight’s “Alzheimer’s Disease Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of

Read Full Article

CRISPR Therapies Pipeline Report: FDA, EMA, and PMDA Approvals, Treatments, Clinical Trials, Phases, and Companies by DelveInsight | Intellia Therapeutics, CRISPR Therapeutics, AstraZeneca, Novartis

CRISPR Therapies Pipeline (New York, USA) “CRISPR therapies Pipeline Insight, 2023” report by DelveInsight outlines comprehensive insights into the present

Read Full Article

Categories